Identification and distribution of the costimulatory receptor CD28 in the mouse
- PMID: 1320641
Identification and distribution of the costimulatory receptor CD28 in the mouse
Abstract
T cell activation requires Ag-specific stimulation mediated by the TCR as well as an additional stimulus provided by Ag presenting cells. On human T cells, it has been shown that antibodies to the Ag CD28 can provide a potent amplification signal for cytokine production and proliferation. Here we describe the production of a mAb to the murine homologue of CD28, and the use of this antibody to examine the function and distribution of CD28 in the mouse. Anti-murine CD28 synergizes with TCR-mediated signals to greatly enhance lymphokine production and proliferation of T cells, and the CD28 signal is not blocked by cyclosporin A. In the peripheral lymphoid organs and in the blood of the mouse, all CD4+ and CD8+ T cells express CD28. In the thymus, CD28 expression is highest on immature CD3-, CD8+ and CD4+8+ cells, and on CD4-8- cells that express alpha beta and tau delta TCR. The level of CD28 on mature CD4+ and CD8+ alpha beta TCR+ thymocytes is two- to fourfold lower than on the immature cells. The potent costimulatory function of CD28 on mature T cells, together with the high level of expression on CD4+8+ thymocytes, suggest that this costimulatory receptor might play an important role in T cell development and activation.
Similar articles
-
Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.J Immunol. 1993 Jul 15;151(2):597-609. J Immunol. 1993. PMID: 7687618
-
B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.J Immunol. 1992 Nov 15;149(10):3217-24. J Immunol. 1992. PMID: 1385518
-
Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.J Immunol. 1995 Feb 1;154(3):985-97. J Immunol. 1995. PMID: 7822814
-
Manipulation of regulatory T-cell number and function with CD28-specific monoclonal antibodies.Adv Immunol. 2007;95:111-48. doi: 10.1016/S0065-2776(07)95004-X. Adv Immunol. 2007. PMID: 17869612 Review.
-
Thy-1: more than a mouse pan-T cell marker.J Immunol. 2004 Sep 15;173(6):3581-8. doi: 10.4049/jimmunol.173.6.3581. J Immunol. 2004. PMID: 15356100 Review.
Cited by
-
Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles.Nanomedicine. 2019 Jun;18:282-291. doi: 10.1016/j.nano.2018.10.001. Epub 2018 Oct 21. Nanomedicine. 2019. PMID: 30352312 Free PMC article. Review.
-
Expression and functional significance of an additional ligand for CTLA-4.Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11054-8. doi: 10.1073/pnas.90.23.11054. Proc Natl Acad Sci U S A. 1993. PMID: 7504292 Free PMC article.
-
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.J Exp Med. 1996 Jun 1;183(6):2533-40. doi: 10.1084/jem.183.6.2533. J Exp Med. 1996. PMID: 8676074 Free PMC article.
-
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.Mol Ther. 2012 Apr;20(4):860-9. doi: 10.1038/mt.2011.281. Epub 2011 Dec 20. Mol Ther. 2012. PMID: 22186790 Free PMC article.
-
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.Ann Surg Oncol. 2005 Dec;12(12):1005-16. doi: 10.1245/ASO.2005.03.536. Epub 2005 Oct 21. Ann Surg Oncol. 2005. PMID: 16283570 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous